Promis Neurosciences Stock Widgets and Gadgets
| PMN Stock | USD 0.96 0.05 4.95% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- PMN ProMIS Neurosciences
- Latest ProMIS Neurosciences to Participate in 7th Annual Evercore HealthCONx Conference
- PMN 0.96 -0.05
- Low 0.96
- High 0.96
- Alpha -0.24
- Beta -0.31
- Return On Equity -10.99
- Return On Asset -4.81
- Current Valuation 10.09 M
- Shares Outstanding 32.69 M
- Shares Owned By Insiders 44.78 %
- Shares Owned By Institutions 50.30 %
- Number Of Shares Shorted 154.56 K
- Price To Book 4.54 X
- Price To Sales 5,168 X
- Gross Profit (16.09 M)
- EBITDA (17.81 M)
- Net Income (17.51 M)
- Cash And Equivalents 8.95 M
- Cash Per Share 1.24 X
- Total Debt 13.07 M
- Debt To Equity 1.08 %
- Current Ratio 5.42 X
- Book Value Per Share 0.20 X
- Cash Flow From Operations (14.37 M)
- Short Ratio 2.64 X
- Earnings Per Share 0.04 X
- Target Price 8.61
- Number Of Employees 6
- Beta 0.61
- Market Capitalization 33.02 M
- Total Asset 18.04 M
- Retained Earnings (123.84 M)
- Working Capital 490.44 K
- Net Asset 18.04 M
- Daily Balance Of Power (9,223,372,036,855)
- Rate Of Daily Change 0.95
- Day Median Price 0.96
- Day Typical Price 0.96
- Price Action Indicator (0.03)
- Period Momentum Indicator (0.05)
Market Snapshot Widget Example
DAX Index Germany | 20,399 0.34 | |
Taiwan Weighted Taiwan | 22,904 0.96 | |
PSI 20 Stock Portugal | 6,352 0.14 | |
CROBEX Croatia | 3,173 0.52 | |
Budapest SE Hungary | 80,531 0.24 | |
IDX 30 Jakarta Indonesia | 457.10 0.07 | |
ISEQ 20 Price Ireland | 1,642 0.39 | |
NYSE Comp USA | 19,891 0.05 | |
Tel Aviv 35 Israel | 2,336 0.69 | |
Coreshares Index Tracker South Afric | 1,087 1.18 | |
IPC MEXICO Mexico | 51,296 0.16 | |
KL Technology Malaysia | 62.40 0.50 | |
IBEX 35 Index Spain | 11,789 1.47 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,627 0.04 | |
SPASX Dividend Opportunities Australia | 1,696 0.38 | |
HNX 30 Vietnam | 485.48 0.81 | |
Bucharest BET-NG Romania | 1,215 1.77 | |
AMS Small Cap Netherlands | 1,251 0.03 | |
Oslo Exchange Mutual Norway | 1,404 0.08 | |
BEL Small Belgium | 8,029 0.04 | |
Basic Materials Brazil | 6,022 0.38 | |
Swiss Leader Price Switzerland | 1,936 0.39 | |
Fondo Mutuo ETF Chile | 1,395 0.20 | |
Athens General Comp Greece | 1,458 0.08 | |
Stock Exchange Of Thailand | 1,443 0.31 | |
PX Prague Stock Czech Repub | 1,722 0.46 | |
THE PHILIPPINE STOCK Philippines | 6,643 1.22 | |
WIG 30 Poland | 2,924 0.72 | |
BIST Electricity Turkey | 507.81 0.56 |
Investing Ideas
In addition to having ProMIS Neurosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare ProMIS Neurosciences
Compare ProMIS Neurosciences To Peers
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProMIS Neurosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in ProMIS Stock, please use our How to Invest in ProMIS Neurosciences guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProMIS Neurosciences. If investors know ProMIS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProMIS Neurosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.04 | Revenue Per Share 0.001 | Return On Assets (4.81) | Return On Equity (10.99) |
The market value of ProMIS Neurosciences is measured differently than its book value, which is the value of ProMIS that is recorded on the company's balance sheet. Investors also form their own opinion of ProMIS Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is ProMIS Neurosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProMIS Neurosciences' market value can be influenced by many factors that don't directly affect ProMIS Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProMIS Neurosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if ProMIS Neurosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProMIS Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.